Skip to content

Brief Mindfulness Intervention vs. Health Enhancement Program for Patients Undergoing Dialysis: A Randomized Controlled Trial

Marouane Nassim, Haley Park, Elena Dikaios, Angela Potes, Sasha Elbaz, Clare Mcveigh, Mark L. Lipman, Márta Novák, Emilie Trinh, Ahsan Alam, Rita S. Suri, Zoë Thomas, Susana Gabriela Torres-Platas, Akshya Vasudev, Neeti Sasi, Maryse Gautier, István Mucsi, Helen Rose Noble, Soham Rej

Healthcare June 1, 2021 DOI: 10.3390/healthcare9060659 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 55
Population Patients receiving maintenance dialysis for end-stage kidney disease with symptoms of depression and/or anxiety
Intervention Brief mindfulness intervention (BMI)
Duration 8 weeks
Measures Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7)
Topics Meditation
Citations 20
Key findings Both a brief mindfulness intervention and an active control (Health Enhancement Program) reduced depression symptoms in dialysis patients, with no difference between arms in secondary analyses. In participants with baseline PHQ-9 scores of 10 or higher, mindfulness produced greater improvement in depression scores, and mindfulness also appeared superior for anxiety symptoms in the primary analysis. The authors conclude both interventions may be helpful for depression, and mindfulness may be superior for anxiety.

Abstract

Background: Between 20-50% of patients undergoing maintenance dialysis for end-stage kidney disease experience symptoms of depression and/or anxiety, associated with increased mortality, greater health care utilization, and decreased quality of life. It is unknown whether mindfulness-based interventions can improve depression and anxiety symptoms in patients receiving this treatment.

Methods: We conducted an 8-week multicenter randomized controlled trial comparing a brief mindfulness intervention (BMI) vs. an active control (Health Enhancement Program [HEP]) in 55 patients receiving dialysis with symptoms of depression and/or anxiety. The primary outcome was change in Patient Health Questionnaire-9 (PHQ-9) depression scores, with a primary analysis in participants with baseline PHQ-9 ≥ 10, and a secondary analysis including all participants. The secondary outcome was change in Generalized Anxiety Disorder-7 (GAD-7) anxiety scores with corresponding primary and secondary analyses.

Results: = 0.01). Secondary analyses revealed no differences between arms.

Conclusions: For patients undergoing dialysis, both BMI and HEP may be helpful interventions for depression symptoms, and BMI may be superior to HEP for anxiety symptoms. Mindfulness-based and other psychosocial interventions may be further evaluated in those undergoing dialysis as treatment options for symptoms of depression and anxiety.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 5

Cites 10

and 5 more in the library

Explore topics